GlassScriptPhysician profile
James R Poston
NPI 1427372986
$16,652.30
in general payments reported to CMS, 2019-2025
74 companies · $3,403 in 2025
The $3,403 reported for 2025 was more than what 80% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,655 · 2020: $1,336 · 2021: $2,544 · 2022: $2,368 · 2023: $2,570 · 2024: $2,776 · 2025: $3,403.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,737 · Education: $11.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,737.02 |
| Education | $11.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,536.34 | 2020-2025 | |
| Emd Serono, INC. | $1,192.85 | 2019-2025 | Mavenclad, Mavenclad |
| Ucb, INC. | $905.30 | 2019-2025 | Briviact, Rystiggo, Nayzilam |
| Pfizer INC. | $898.58 | 2019-2025 | |
| Supernus Pharmaceuticals, INC. | $754.91 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $740.05 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Sk Life Science, INC. | $671.50 | 2020-2025 | |
| Novartis Pharmaceuticals Corporation | $570.27 | 2019-2025 | |
| Eisai INC. | $563.60 | 2019-2025 | |
| Neurelis, INC. | $546.71 | 2020-2025 | Valtoco |
| Lundbeck LLC | $528.19 | 2021-2025 | Rexulti, Vyepti |
| Biogen, INC. | $433.85 | 2019-2025 | Leqembi, Skyclarys |
| Amgen INC. | $424.57 | 2019-2025 | Uplizna, Aimovig |
| Csl Behring | $369.43 | 2019-2025 | Hizentra |
| Genentech USA, INC. | $343.33 | 2019-2025 | Ocrevus Zunovo, Ocrevus |
Show all 74 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Poston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.